Teleflex Incorporated TFX today announced that the ARROW UltraQuik
peripheral nerve block (PNB) needles have received 510(k) clearance from the
U.S. Food and Drug Administration (FDA).
ARROW UltraQuik peripheral nerve block needles are designed to help increase
overall block success for clinicians who use ultrasound-guidance when
performing single-injection PNBs. UltraQuik needles maintain many of the same
clinician-inspired features of the ARROW^® StimuQuik^® ECHO needles, including
five grooved rings at the distal tip of the needle to help clinicians identify
the needle tip under ultrasound.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in